At 35 days after inoculation, the mice were killed, and the mice injected with HepG2‐NOLC1 and SMMC7721‐NOLC1 cells displayed a larger burden (Fig. 6F and G), which indicated that NOLC1 may participate in HCC tumor proliferation. This evidence concerns the gene NOLC1 and neoplasm.